Stämm is a biotechnology company developing novel, fully automated bioprocessors to transform biologics production. Our continuous, bubble-free manufacturing platform with a novel 3D printed bioreactor enhances yields, reduces costs, and minimizes footprint and energy consumption. Our approach enables a scalable and energy-efficient solution for challenging biologics and cell therapy manufacturing.